Gender-based differences in cardiovascular mortality may be due to a cardio-protective effect of oestrogens on the myocardium. However, mRNA expression of oestrogen receptors in myocardial tissue of the adult heart has yet to be demonstrated. Furthermore, a calcium antagonistic action of 17beta-oestradiol on myocardial tissue has been discussed. Therefore, two subjects were investigated in atrial myocytes of the human, and ventricular myocytes of guinea-pig and rat in this study. (1) Are oestrogen receptors expressed in adult myocardial cells? (2) Is there an influence of oestrogens on the L-type calcium current of cardiac myocytes? Expression of oestrogen receptors was investigated by reverse polymerase chain reaction. L-type calcium current was usually measured by the patch-clamp technique in whole-cell recording mode under selective recording conditions, i.e. overlapping currents were blocked. One series of experiments was performed in perforated patch configuration to avoid internal perfusion. 17beta-oestradiol inhibited L-type calcium current reversibly in all three species. At 10(-5) M, the inhibition was 15-20%. This inhibition was independent of the sex and the species. A full concentration response curve of 17beta-oestradiol on basal L-type current was recorded from female guinea-pig myocytes. The inhibition increased from 2% at 10(-7) M to about 30% at 10(-4) M 17beta-oestradiol. The values could be fitted by a sum of two sigmoidal functions with log EC50 values of -6.5 and -4.9 M and Hill slopes of 2.5 for both. The specificity of the 17beta-oestradiol action was tested by recording the L-type current in the presence of 17alpha-oestradiol and oestrone. 17alpha-oestradiol also inhibited the current, but with a maximal inhibition of only 17%. The concentration-response curve could be fitted by a single sigmoidal function (log EC50 -6-3 M; Hill slope 0.55). Oestrone did not influence the current at all. The decrease in L-type current after the application of 17beta-oestradiol via a rapid perfusion system developed with a time constant of 3-4 s, which was in the same range as that for the influence of isoprenaline. The isoprenaline-stimulated L-type current was much more susceptible to the inhibition by 17beta-oestradiol, i.e. in pre-stimulated cells (1) the inhibitory effect is significantly higher (e.g. at 10(-5) M, inhibition was 36.3% compared with 11.2% in untreated cells) and (2) an inhibitory effect can be seen with oestradiol concentrations as low as 10(-9) M. Although the concentrations needed to gain a calcium antagonistic influence on the basal current were much too high to explain a cardio-protective influence of oestrogens, the presence of oestrogen receptors in cardiac myocytes of all three species, together with the shift in concentration dependence following pre-stimulation by isoprenaline, suggest that myocytes are a potential target for oestrogen.

This article has been cited by other articles:

				N. D. Ullrich, A. Krust, P. Collins, and K. T. MacLeod Genomic deletion of estrogen receptors ER{alpha} and ER{beta} does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2421 - H2427. [Abstract] [Full Text] [PDF]

				J. A. Browning, H. M. Staines, H. C. Robinson, T. Powell, J. C. Ellory, and J. S. Gibson The effect of deoxygenation on whole-cell conductance of red blood cells from healthy individuals and patients with sickle cell disease Blood, March 15, 2007; 109(6): 2622 - 2629. [Abstract] [Full Text] [PDF]

				O. J. Kemi, P. M. Haram, J. P. Loennechen, J.-B. Osnes, T. Skomedal, U. Wisloff, and O. Ellingsen Moderate vs. high exercise intensity: Differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function Cardiovasc Res, July 1, 2005; 67(1): 161 - 172. [Abstract] [Full Text] [PDF]

				K. W. L. Kam, J. S. Qi, M. Chen, and T. M. Wong Estrogen Reduces Cardiac Injury and Expression of {beta}1-Adrenoceptor upon Ischemic Insult in the Rat Heart J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 8 - 15. [Abstract] [Full Text]

				Y. Li, I. Kishimoto, Y. Saito, M. Harada, K. Kuwahara, T. Izumi, I. Hamanaka, N. Takahashi, R. Kawakami, K. Tanimoto, et al. Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-A Endocrinology, February 1, 2004; 145(2): 951 - 958. [Abstract] [Full Text] [PDF]

				R. Liew, M. A Stagg, J. Chan, P. Collins, and K. T MacLeod Gender determines the acute actions of genistein on intracellular calcium regulation in the guinea-pig heart Cardiovasc Res, January 1, 2004; 61(1): 66 - 76. [Abstract] [Full Text] [PDF]

				H. Y. Chan, X. Yao, S. Y. Tsang, J.-P. Bourreau, F. L. Chan, and Y. Huang Isoproterenol amplifies 17{beta}-estradiol-mediated vasorelaxation: role of endothelium/nitric oxide and cyclic AMP Cardiovasc Res, February 15, 2002; 53(3): 627 - 633. [Abstract] [Full Text] [PDF]

				F. A Babiker, L. J De Windt, M. van Eickels, C. Grohe, R. Meyer, and P. A Doevendans Estrogenic hormone action in the heart: regulatory network and function Cardiovasc Res, February 15, 2002; 53(3): 709 - 719. [Abstract] [Full Text] [PDF]

				H.-Y. Li, J.-S. Bian, Y. W. Kwan, and T. M. Wong Enhanced Responses to 17beta -Estradiol in Rat Hearts Treated with Isoproterenol: Involvement of a Cyclic AMP-Dependent Pathway J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 592 - 598. [Abstract] [Full Text]

				S. Nuedling, S. Kahlert, K. Loebbert, P. A. Doevendans, R. Meyer, H. Vetter, and C. Grohe 17{beta}-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo Cardiovasc Res, August 15, 1999; 43(3): 666 - 674. [Abstract] [Full Text] [PDF]

				S. Tanabe, T. Hata, and M. Hiraoka Effects of estrogen on action potential and membrane currents in guinea pig ventricular myocytes Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H826 - H833. [Abstract] [Full Text] [PDF]

				S. Kahlert, S. Nuedling, M. van Eickels, H. Vetter, R. Meyer, and C. Grohe Estrogen Receptor alpha Rapidly Activates the IGF-1 Receptor Pathway J. Biol. Chem., June 9, 2000; 275(24): 18447 - 18453. [Abstract] [Full Text] [PDF]